Andrea Easom, MA, MNSC, APRN, BC, CNN
Instructor, College of Medicine
Family Nurse Practitioner
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Vaughn Folkert, MD
Director of Clinical Nephrology
Weiler Hospital of Albert Einstein College of Medicine
Associate Professor of Clinical Medicine
Albert Einstein College of Medicine
Bronx, New York
This satellite symposium
is sponsored by an unrestricted educational grant
from Watson Pharma, Inc. This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held on September 25, 2005 at the American Nephrology
Nurses' Association (ANNA) Annual Meeting in Las Vegas, Nevada.
This symposium was approved
by ANNA. It was not part of the official ANNA
This activity has been awarded 1.5 contact hours by
the American Nephrology Nurses Association (ANNA) which
is accredited as a provider and approver of continuing
education in nursing by the American Nurses Credentialing
Center-Commission on Accreditation (ANCC-COA).
After participating in this program, the participant should be able to:
Posting Date: January 15, 2006
CE Credit Eligible Through: January 15, 2007
CE Credit Hours/Completion Time: 1.5
Target Audiences: Nurses, nurse practitioners, and other healthcare professionals who treat and manage patients with CKD.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material.
- Define serum ferritin and the current understanding of it in terms of safety and efficacy
- Review K/DOQI recommendations for treating patients based on serum ferritin levels
- Describe special concerns that exist in treating anemia in pediatric patients on dialysis
- Discuss dosing guidelines for administering IV iron in pediatric patients
- Evaluate the safety and efficacy of IV iron therapy
See individual talks.
| SPEAKER DISCLOSURE STATEMENT:
This ANNA Satellite symposium was developed in conjunction with Fallon Medica,
and the ANNA, and sponsored by a restricted educational grant from Watson Pharma, Inc.
The CE policy and disclosure statements of the American Nephrology Nurses' Association
are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are
| ANNA and HDCN CE POLICY